About this trial
This study aims to investigate the relationship between urinary incontinence severity and surface electromyography (EMG) findings in women with multiple sclerosis. It will also examine the association of urinary incontinence with disability, quality of life, physical activity, and fatigue.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
The study will include female patients with multiple sclerosis (MS) aged 30-50 years, diagnosed according to the 2017 revised McDonald criteria, who experience urinary incontinence symptoms according to the International Continence Society (ICS) definition and have an EDSS score below 6.5. Participants must be able to communicate effectively. Patients who do not provide consent, have had a medication change within the last 6 months, are pregnant, have had a vaginal or cesarean delivery within the last 6 months, have pelvic organ prolapse, or have a urinary tract infection will be excluded.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Pelvic floor muscle activity with surface EMG
Evaluated using biofeedback-assisted surface EMG. Metrics recorded include mean EMG activity during contraction and rest phases, standard deviation of EMG activity, peak and minimum EMG values, contraction onset, and relaxation times
Secondary outcomes
International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)
Assesses severity and impact of urinary incontinence
Incontinence Impact Questionnaire (IIQ-7)
Evaluates the effect of urinary incontinence on quality of life
International Physical Activity Questionnaire (IPAQ)
Assesses participants' physical activity levels
Fatigue Severity Scale (FSS)
Measures severity of fatigue experienced by participants
Sponsors and contacts
Click on the lead sponsor to view all of their trials.